Company intelligence / Profile preview

Vatic Health

London, England, United Kingdomvaticpro.com ↗

Ownership: Private
Development stage: Other

Overview

Vatic Health developed a patented rapid antigen test ("KnowNow Test") that detects if a person is currently contagious with COVID‑19 rather than just infected. The company focused on providing lab-grade, at-home diagnostic solutions using proprietary assay technology to enable early disease detection and reduce hospitalizations. No published clinical trial results are available; the main product was commercialized during the pandemic. Company now liquidating.

Therapeutic areas: Infectious DiseasesOther
Modalities: DeviceAssay chemistry platform
Industry: Protein Biomarker Diagnostics

Beyond the preview

Go deeper on Vatic Health.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vatic Health.

Explore the full profile